![]()  | 
![]()  | ![]()  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
    
     
    
    
 
    
    
    
There has been a lot of buzz about this company the last couple of weeks.  I'm in check it out for yourself. Business Summary IMPH provides the expertise to establish correct diagnosis, accurate prognosis, treatment determination and patient follow-up info. focused exclusively on cancer. For the nine months ended 9/97, revenues rose 74% to $26.5 million. Net income applicable to Common rose 98% to $2.4 million. Revenues reflect an increase in case volume resulting from increased sales and marketing activities. Earnings also reflect lower salaries and related costs as a percentage of sales. Here is a link for your own DD. dailystocks.com The float is only 3.2 million, rumor has it that big money is coming in. Target price 55 in 98. SK  | ||||||||||||||
 
        
 
  | 
    
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |